The Meldofsky Firm Reports That Xarelto Law Suits Continue to Spiral with 400 New Cases in One Month
Xarelto is a blood thinning drug designed to help people with blood clotting disorders and other related conditions, and is approved by the FDA. Unlike other blood thinning drugs however, Xarelto has no known antidote, and users have been injured or even died as a result of intestinal and rectal bleeding, blood clots, uncontrolled bleeding events and even brain hemorrhages. The Meldofsky Firm has created a resource center, Xarelto Injury Lawsuits, to report on the development of the cases. Their...
View full press release